iQIYI
IQ
1.02
+0.01
+0.99%
iQIYI
US · IQ
#3268 by market cap
1.02
+0.01
+0.99%
Live - 5344 symbols - heartbeat 109s ago
· 2026-10-09 19:29
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is -1.00, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -6.62% YoY
Margins
- Gross margin
- 21.07%
- Operating margin
- 0.84%
- Net margin
- -0.76%
Key ratios & quality
- Enterprise valuei
- 11.22B
- Altman Z-Scorei
- -1.00
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 24.99B | 28.99B | 29.71B | 30.55B | 29.00B | 31.87B | 29.23B | 27.29B |
| Gross profit | -2.14B | -1.35B | 1.82B | 3.04B | 6.68B | 8.77B | 7.27B | 5.75B |
| Selling & admin expenses | 4.17B | 5.24B | 5.19B | 4.73B | 3.47B | 4.01B | 3.68B | 3.86B |
| Research & development | 1.99B | 2.67B | 2.68B | 2.79B | 1.90B | 1.77B | 1.78B | 1.66B |
| Operating profit | -8.31B | -9.26B | -6.04B | -4.48B | 1.31B | 2.99B | 1.81B | 229.32M |
| Pretax profit | -8.98B | -10.22B | -6.98B | -6.01B | -33.78M | 2.03B | 851.68M | -59.50M |
| Tax | 78.80M | 51.85M | 23.28M | 96.55M | 84.00M | 80.05M | 61.09M | 144.54M |
| Net profit | -9.06B | -10.28B | -7.01B | -6.11B | -117.78M | 1.95B | 790.59M | -204.04M |
| Basic EPS | -17 | -14 | -10 | -8 | 0 | 2 | 1 | 0 |
| Diluted EPS | -17.01 | -14.14 | -9.52 | -7.77 | -0.14 | 1.96 | 0.77 | -0.21 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 7.19B | 6.63B | 6.68B | 6.79B | 6.23B | 6.29B |
| Gross profit | 1.78B | 1.34B | 1.22B | 1.42B | 992.29M | 1.04B |
| Selling & admin expenses | 1.03B | 959.60M | 925.02M | 946.18M | 816.53M | 744.23M |
| Research & development | 412.49M | 421.92M | 412.14M | 416.54M | 404.19M | 398.02M |
| Operating profit | 341.90M | -46.17M | -121.81M | 55.40M | -228.43M | -104.76M |
| Pretax profit | 227.22M | -108.07M | -206.90M | 28.24M | -256.39M | -110.25M |
| Tax | 41.59M | 27.16M | 40.04M | 35.76M | 37.16M | 219.78M |
| Net profit | 185.63M | -135.22M | -246.94M | -7.52M | -293.55M | -330.03M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.21 | -0.14 | -0.28 | 0.00 | -0.28 | -0.28 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 19.85B | 20.27B | 22.29B | 11.52B | 13.79B | 12.64B | 9.53B | 10.29B |
| Cash & ST investments | 10.65B | 10.51B | 14.27B | 4.35B | 7.92B | 5.38B | 4.47B | 4.67B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 44.76B | 44.79B | 48.19B | 42.47B | 46.05B | 44.59B | 45.76B | 46.68B |
| Total current liabilities | 19.81B | 20.17B | 24.85B | 22.48B | 28.13B | 22.34B | 21.48B | 22.07B |
| Short-term debt | 3.13B | 3.48B | 8.83B | 4.29B | 12.46B | 6.53B | 4.34B | 4.82B |
| Long-term debt | 5.36B | 13.18B | 11.93B | 12.65B | 9.57B | 8.24B | 9.39B | 10.08B |
| Total liabilities | 26,604,135,000.00 | 35,077,618,000.00 | 38,741,131,000.00 | 36,799,052,000.00 | 39,704,910,000.00 | 32,409,459,000.00 | 32,386,761,000.00 | 33,372,809,000.00 |
| Total equity | 18.16B | 9.71B | 9.44B | 5.67B | 6.34B | 12.18B | 13.37B | 13.31B |
| Retained earnings | -23.51B | -33.83B | -40.97B | -47.16B | -46.50B | -44.57B | -43.81B | -44.02B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 10.81B | 9.46B | 9.36B | 10.29B | 9.72B | 9.66B |
| Cash & ST investments | 5.27B | 4.25B | 4.07B | 4.67B | 3.61B | 4.12B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 47.12B | 46.36B | 45.79B | 46.68B | 46.17B | 45.42B |
| Total current liabilities | 23.65B | 22.54B | 21.29B | 22.07B | 21.60B | 21.50B |
| Short-term debt | 6.23B | 5.04B | 4.41B | 4.82B | 3.56B | 3.63B |
| Long-term debt | 8.36B | 9.04B | 9.98B | 10.08B | 10.33B | 10.16B |
| Total liabilities | 33,481,655,000.00 | 32,854,343,000.00 | 32,454,569,000.00 | 33,372,809,000.00 | 33,151,809,000.00 | 32,852,634,000.00 |
| Total equity | 13.64B | 13.51B | 13.33B | 13.31B | 13.02B | 12.57B |
| Retained earnings | -43.63B | -43.76B | -44.01B | -44.02B | -44.31B | -44.60B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.88B | 3.91B | -5.41B | -5.95B | -70.57M | 3.35B | 2.11B | 105.80M |
| Depreciation & amortization | 15.16B | 17.17B | 17.20B | 16.77B | 13.66B | 14.09B | 13.63B | 13.26B |
| Free cash flow | -11.16B | -8.92B | -5.80B | -6.35B | -340.34M | 3.25B | 1.94B | -18.84M |
| Dividends paid | 0 | 0 | -62.43M | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 14.90B | 0 | 4.46B | 500.38M | 1.81B | 3.39B | 0 | 0 |
| Ending cash balance | 6.76B | 6.91B | 10.94B | 3.07B | 7.86B | 5.28B | 3.59B | 4.38B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 338.95M | -12.73M | -267.58M | 47.16M | 186.45M | 339.58M |
| Depreciation & amortization | -- | -- | -- | -- | -- | -- |
| Free cash flow | 338.95M | -12.73M | -267.58M | -77.47M | 186.45M | 339.58M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 4.76B | 4.14B | 4.77B | 4.38B | 3.32B | 3.21B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -71.51 | -74.80 | -74.84 | -85.71 | -2.38 | 21.00 | 6.00 | -1.55 |
| ROA %i | -28.97 | -23.06 | -15.16 | -13.66 | -0.31 | 4.25 | 1.69 | -0.45 |
| ROIC %i | -53.67 | -37.40 | -22.17 | -19.68 | 1.37 | 9.97 | 5.45 | 0.80 |
| 5-year avg ROE %i | -- | -- | -- | -- | -148.88 | -43.35 | -27.19 | -12.53 |
| EBIT margin %i | -35.57 | -32.11 | -19.92 | -15.26 | 2.35 | 9.92 | 6.55 | 3.12 |
| FCF / sales %i | -- | -- | -- | -- | -- | 10.19 | 6.63 | -- |
| Current ratioi | 1.00 | 1.00 | 0.90 | 0.51 | 0.49 | 0.57 | 0.44 | 0.47 |
| Quick ratioi | 0.79 | 0.82 | 0.79 | 0.41 | 0.44 | 0.51 | 0.40 | 0.42 |
| Debt / assetsi | 18.96 | 38.09 | 44.67 | 41.36 | 48.93 | 34.29 | 31.02 | 32.66 |
| LT debt / equityi | 29.70 | 141.89 | 137.14 | 255.95 | 161.21 | 72.52 | 73.69 | 78.26 |
| Interest coveragei | -93.84 | -10.18 | -5.55 | -3.45 | 0.95 | 2.80 | 1.80 | 0.93 |
| Revenue CAGR (3Y) %i | 67.49 | 37.16 | 19.57 | 6.93 | 0.00 | 2.37 | -1.47 | -2.00 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 2.21 | 0.67 | -- | -1.55 | -5.11 | -6.39 |
| ROA %i | 0.62 | 0.19 | -- | -0.45 | -1.46 | -1.82 |
| ROIC %i | 3.00 | 2.00 | -- | 0.80 | -1.25 | -1.92 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.95 | 4.14 | -- | 3.12 | 1.32 | 1.14 |
| FCF / sales %i | 4.70 | 3.31 | -- | -- | -- | 0.70 |
| Current ratioi | 0.46 | 0.42 | 0.44 | 0.47 | 0.45 | 0.45 |
| Quick ratioi | 0.33 | 0.30 | 0.31 | 0.42 | 0.30 | 0.32 |
| Debt / assetsi | 31.89 | 31.15 | 32.20 | 32.66 | 30.80 | 31.09 |
| LT debt / equityi | 64.47 | 69.55 | 77.43 | 78.26 | 81.55 | 82.82 |
| Interest coveragei | 1.39 | 1.19 | -- | 0.93 | 0.39 | 0.35 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-09 19:29:49 · For reference only, not investment advice and not tailored to your situation.
iQIYI discussion 0 comments